Results 201 to 210 of about 13,123 (252)

Comparison of the Efficacy of First-Line Pemetrexed-Platinum and Gemcitabine-Platinum Regimens in Malignant Peritoneal Mesothelioma. [PDF]

open access: yesClin Med Insights Oncol
Bayram D   +10 more
europepmc   +1 more source

Peritonectomy HIPEC-contemporary results, indications.

open access: yesChinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2013
openaire   +1 more source

Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer

Oncology, 2023
Introduction: This study examined the difference in overall survival (OS) between peritoneal metastatic gastric cancer (PMGC) patients who underwent neoadjuvant chemotherapy followed by cytoreductive surgery ± hyperthermic intraperitoneal chemotherapy ...
Selin Akturk Esen   +6 more
semanticscholar   +1 more source

Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis

Annals of Surgical Oncology, 2007
Peritonectomy with heated intraperitoneal chemotherapy (HIPEC) has shown a survival benefit in selected patients with peritoneal carcinomatosis. This prospective non-randomized study was designed to identify factors associated with postoperative morbidity and survival after peritonectomy HIPEC in patients with this condition.Data were prospectively ...
B L, van Leeuwen   +3 more
openaire   +2 more sources

HIPEC in Pediatric Patients

2021
Peritoneal carcinomatosis and peritoneal sarcomatosis in children are rare and might occur in colorectal cancer, desmoplastic small round cell tumors (DSRCT), rhabdomyosarcoma, and other entities. The treatment of these children is still a major challenge as despite very intensive therapies consisting of systemic chemotherapy, radiotherapy, and surgery,
Guido Seitz, Jörg Fuchs, Stefan Beckert
openaire   +1 more source

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

Journal of Clinical Oncology, 2018
LBA3503 Background: Promising results have been obtained during the last decade using cytoreductive surgery (CRS) plus HIPEC for selected patients with colorectal PC who are amenable to complete macroscopic resection.
F. Quénet   +16 more
semanticscholar   +1 more source

Rationale Behind HIPEC/Molecular and Genetic Considerations in HIPEC

2019
The series of molecular events comprising the metastatic cascade in peritoneal carcinomatosis is complex. The tumor microenvironment is rich in factors regulating cell proliferation, DNA repair, and senescence. Combined hyperthermia and intraperitoneal chemotherapy are utilized in conjunction with cytoreductive surgery for peritoneal surface ...
Jula Veerapong, Andrew M. Lowy
openaire   +1 more source

Peritonektomie und HIPEC

2018
Die peritoneale Metastasierung gastrointestinaler Tumoren wurde fruher grundsatzlich palliativ behandelt. Die kombinierte Behandlungsstrategie der „zytoreduktiven Chirurgie“ und „hyperthermen intraperitonealen Chemotherapie“ (HIPEC) nutzt Verfahren der Peritonektomie und viszeralen Organresektionen, um Tumorformationen vollstandig zu entfernen oder zu ...
C. Yurttas   +4 more
openaire   +1 more source

HIPEC im Kindesalter

2018
Die Peritonealkarzinose und Peritonealsarkomatose sind im Kindesalter selten. Die zytoreduktive Chirurgie in Kombination mit HIPEC stellt einen neuen, innovativen Therapieansatz fur Kinder und Jugendliche mit Weichteilsarkomen (Rhabdomyosarkome, desmoplastische klein- und rundzellige Tumoren) und kolorektalen Karzinomen dar.
G. Seitz, J. Fuchs, S. Beckert
openaire   +1 more source

Home - About - Disclaimer - Privacy